Successful Chemotherapy with Carboplatin and S-1 for Thymic Carcinoma: A Case Report

por Igawa, Satoshi, Yanagisawa, Nobuyuki, Ishihara, Mikiko, Kimura, Michiko, Maki, Sachiyo, Otani, Sakiko, Sasaki, Jiichiro, Masuda, Noriyuki
Publicado 2013

Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer

por Fukui, Tomoya, Itabashi, Michiko, Ishihara, Mikiko, Hiyoshi, Yasuhiro, Kasajima, Masashi, Igawa, Satoshi, Sasaki, Jiichiro, Masuda, Noriyuki
Publicado 2016

Successful Chemotherapy with Nab-Paclitaxel in a Heavily Treated Non-Small Cell Lung Cancer Patient: A Case Report

por Ishihara, Mikiko, Igawa, Satoshi, Maki, Sachiyo, Harada, Shinya, Kusuhara, Seiichiro, Niwa, Hideyuki, Otani, Sakiko, Sasaki, Jiichiro, Jiang, Shi-Xu, Masuda, Noriyuki
Publicado 2014

Questionnaire survey on patient awareness of invasive rebiopsy in advanced non‐small cell lung cancer

por Fukui, Tomoya, Ishihara, Mikiko, Kasajima, Masashi, Hiyoshi, Yasuhiro, Nakahara, Yoshiro, Otani, Sakiko, Igawa, Satoshi, Yokoba, Masanori, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2019

Impact of EGFR genotype on the efficacy of osimertinib in EGFR tyrosine kinase inhibitor-resistant patients with non-small cell lung cancer: a prospective observational study

por Igawa, Satoshi, Ono, Taihei, Kasajima, Masashi, Ishihara, Mikiko, Hiyoshi, Yasuhiro, Kusuhara, Seiichiro, Nishinarita, Noriko, Fukui, Tomoya, Kubota, Masaru, Sasaki, Jiichiro, Hisashi, Mitsufuji, Yokoba, Masanori, Katagiri, Masato, Naoki, Katsuhiko
Publicado 2019

Evaluation of osimertinib efficacy according to body surface area and body mass index in patients with non‐small cell lung cancer harboring an EGFR mutation: A prospective observat...

por Ono, Taihei, Igawa, Satoshi, Ozawa, Takahiro, Kasajima, Masashi, Ishihara, Mikiko, Hiyoshi, Yasuhiro, Kusuhara, Seiichiro, Nishinarita, Noriko, Fukui, Tomoya, Kubota, Masaru, Sasaki, Jiichiro, Hisashi, Mitsufuji, Katagiri, Masato, Naoki, Katsuhiko
Publicado 2019

Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer

por Shirasawa, Masayuki, Fukui, Tomoya, Kusuhara, Seiichiro, Hiyoshi, Yasuhiro, Ishihara, Mikiko, Kasajima, Masashi, Nakahara, Yoshiro, Otani, Sakiko, Igawa, Satoshi, Yokoba, Masanori, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2018

Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer

por Shirasawa, Masayuki, Fukui, Tomoya, Kusuhara, Seiichiro, Harada, Shinya, Nishinarita, Noriko, Hiyoshi, Yasuhiro, Ishihara, Mikiko, Kasajima, Masashi, Igawa, Satoshi, Yokoba, Masanori, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2019

Amrubicin monotherapy for elderly patients with relapsed extensive‐disease small‐cell lung cancer: A retrospective study

por Sone, Hideyuki, Igawa, Satoshi, Kasajima, Masashi, Ishihara, Mikiko, Hiyoshi, Yasuhiro, Hosotani, Shinji, Ohe, Shuntaro, Ito, Hiroki, Kaizuka, Nobuki, Manaka, Hiroya, Fukui, Tomoya, Mitsufuji, Hisashi, Kubota, Masaru, Katagiri, Masato, Sasaki, Jiichiro, Naoki, Katsuhiko
Publicado 2018